Cargando…

Targeting Pseudomonas aeruginosa in the Sputum of Primary Ciliary Dyskinesia Patients with a Combinatorial Strategy Having Antibacterial and Anti-Virulence Potential

In primary ciliary dyskinesia (PCD) patients, Pseudomonas aeruginosa is a major opportunistic pathogen, frequently involved in chronic infections of the lower airways. Infections by this bacterial species correlates with a worsening clinical prognosis and recalcitrance to currently available therape...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maisetta, Giuseppantonio, Grassi, Lucia, Esin, Semih, Kaya, Esingül, Morelli, Andrea, Puppi, Dario, Piras, Martina, Chiellini, Federica, Pifferi, Massimo, Batoni, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981532/ https://www.ncbi.nlm.nih.gov/pubmed/31861859 http://dx.doi.org/10.3390/ijms21010069

Ejemplares similares

Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?
por: Batoni, Giovanna, et al.
Publicado: (2022)

In vitro Interaction of Pseudomonas aeruginosa Biofilms With Human Peripheral Blood Mononuclear Cells
por: Kaya, Esingül, et al.
Publicado: (2020)

Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of Pseudomonas aeruginosa under Conditions Relevant to Cystic Fibrosis
por: Batoni, Giovanna, et al.
Publicado: (2023)

Planktonic and Biofilm-Associated Pseudomonas aeruginosa and Staphylococcus epidermidis Elicit Differential Human Peripheral Blood Cell Responses
por: Kaya, Esingül, et al.
Publicado: (2021)

Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis
por: Piras, Anna M., et al.
Publicado: (2015)

The Anti-Microbial Peptide (Lin-SB056-1)(2)-K Reduces Pro-Inflammatory Cytokine Release through Interaction with Pseudomonas aeruginosa Lipopolysaccharide
por: Grassi, Lucia, et al.
Publicado: (2020)

Lactobacillus Probiotic Strains Differ in Their Ability to Adhere to Human Lung Epithelial Cells and to Prevent Adhesion of Clinical Isolates of Pseudomonas aeruginosa from Cystic Fibrosis Lung
por: Batoni, Giovanna, et al.
Publicado: (2023)

The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum
por: Maisetta, Giuseppantonio, et al.
Publicado: (2017)

Antivirulence Properties of a Low-Molecular-Weight Quaternized Chitosan Derivative against Pseudomonas aeruginosa
por: Maisetta, Giuseppantonio, et al.
Publicado: (2021)

Combination Strategies to Enhance the Efficacy of Antimicrobial Peptides against Bacterial Biofilms
por: Grassi, Lucia, et al.
Publicado: (2017)

Antibacterial, Antibiofilm, and Antiadhesive Properties of Different Quaternized Chitosan Derivatives
por: Piras, Anna Maria, et al.
Publicado: (2019)

Therapeutic Potential of Antimicrobial Peptides in Polymicrobial Biofilm-Associated Infections
por: Batoni, Giovanna, et al.
Publicado: (2021)

Microbial Biofilms and Antibiofilm Agents 2.0
por: Batoni, Giovanna, et al.
Publicado: (2022)

Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide
por: Grassi, Lucia, et al.
Publicado: (2017)

Correction: Piras, A.M., et al. Antibacterial, Antibiofilm, and Antiadhesive Properties of Different Quaternized Chitosan Derivatives. Int. J. Mol. Sci. 2019, 20, 6297
por: Piras, Anna Maria, et al.
Publicado: (2021)

Generation of Persister Cells of Pseudomonas aeruginosa and Staphylococcus aureus by Chemical Treatment and Evaluation of Their Susceptibility to Membrane-Targeting Agents
por: Grassi, Lucia, et al.
Publicado: (2017)

Tannin profile, antioxidant properties, and antimicrobial activity of extracts from two Mediterranean species of parasitic plant Cytinus
por: Maisetta, Giuseppantonio, et al.
Publicado: (2019)

The Antimicrobial Peptide lin-SB056-1 and Its Dendrimeric Derivative Prevent Pseudomonas aeruginosa Biofilm Formation in Physiologically Relevant Models of Chronic Infections
por: Grassi, Lucia, et al.
Publicado: (2019)

Editorial: Interspecies Interactions: Effects on Virulence and Antimicrobial Susceptibility of Bacterial and Fungal Pathogens
por: Maisetta, Giuseppantonio, et al.
Publicado: (2020)

Combination of Two Kinds of Medicated Microparticles Based on Hyaluronic Acid or Chitosan for a Wound Healing Spray Patch
por: Fabiano, Angela, et al.
Publicado: (2021)

Insights into the Antimicrobial Properties of Hepcidins: Advantages and Drawbacks as Potential Therapeutic Agents
por: Lombardi, Lisa, et al.
Publicado: (2015)

Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein
por: Grassiri, Brunella, et al.
Publicado: (2023)

Sputum from patients with primary ciliary dyskinesia contains high numbers of dysfunctional neutrophils and inhibits efferocytosis
por: Blanter, Marfa, et al.
Publicado: (2022)

Diagnosis of primary ciliary dyskinesia
por: Olm, Mary Anne Kowal, et al.
Publicado: (2015)

Perspectives for Primary Ciliary Dyskinesia
por: Bukowy-Bieryllo, Zuzanna, et al.
Publicado: (2022)

Variation in treatment strategies for the eradication of Pseudomonas aeruginosa in primary ciliary dyskinesia across European centers
por: Crowley, Suzanne, et al.
Publicado: (2018)

Exacerbations and Pseudomonas aeruginosa colonization are associated with altered lung structure and function in primary ciliary dyskinesia
por: Piatti, G., et al.
Publicado: (2020)

Diagnosis and management of primary ciliary dyskinesia
por: Lucas, Jane S, et al.
Publicado: (2014)

Diagnosis and management of primary ciliary dyskinesia
por: Werner, Claudius, et al.
Publicado: (2015)

Primary ciliary dyskinesia: mechanisms and management
por: Damseh, Nadirah, et al.
Publicado: (2017)

Mucus Plugging in Primary Ciliary Dyskinesia
por: Adaikalam, Stephanie, et al.
Publicado: (2023)

Additive Manufacturing of Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)/poly(ε-caprolactone) Blend Scaffolds for Tissue Engineering
por: Puppi, Dario, et al.
Publicado: (2017)

Towards gene therapy for primary ciliary dyskinesia
por: Munye, M, et al.
Publicado: (2012)

Accuracy of diagnostic testing in primary ciliary dyskinesia
por: Jackson, Claire L., et al.
Publicado: (2016)

Recent advances in primary ciliary dyskinesia genetics
por: Kurkowiak, Małgorzata, et al.
Publicado: (2015)

Primary Ciliary Dyskinesia with Refractory Chronic Rhinosinusitis
por: Suzaki, Isao, et al.
Publicado: (2020)

The Controversies and Difficulties of Diagnosing Primary Ciliary Dyskinesia
por: Shoemark, Amelia, et al.
Publicado: (2020)

Management of a child with primary ciliary dyskinesia
por: Kumar, Aneeta, et al.
Publicado: (2020)

Respiratory Distress in the Newborn with Primary Ciliary Dyskinesia
por: Machogu, Evans, et al.
Publicado: (2021)

Current and Future Treatments in Primary Ciliary Dyskinesia
por: Paff, Tamara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pc9s7uhjt4s8llpch3m0pjqku3